Granules India receives ANDA approval for Trazodone Tablets
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
The company has posted net profit of Rs. 405.31 crores for the Financial Year ended March 31, 2024
Colchicine Capsules are indicated for prophylaxis of gout flares in adult
This facility manufactures APIs & formulations of oncology and non-oncology products.
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Subscribe To Our Newsletter & Stay Updated